Trials / Completed
CompletedNCT03369249
Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 307 (actual)
- Sponsor
- New York State Psychiatric Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This research study proposes to embed HIV testing outreach workers from a young adult focused medical and HIV treatment program into an alternative sentencing program to deliver a new service delivery model (Link2CARE) that integrates evidence-based protocols for justice-involved young adults to: a) promote HIV and STI testing, and HIV and SU risk screening, b) provide onsite intervention, and c) cross-system linkage to HIV, STI, and SU care. Phase 1 has already been completed. In phase 1, the intervention components were adapted for use among justice involved young adults and the resulting protocols were piloted with justice involved young adults, finalizing the resulting 4-session Link2CARE intervention. In phase 2, we will test Link2CARE among N=450 justice-involved young adults enrolled at the alternative sentencing program and conduct process evaluations with N=15 alternative sentencing program staff.
Conditions
- HIV/AIDS
- HIV Infections
- Substance Use
- Substance Abuse
- Substance Use Disorders
- Sexually Transmitted Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Link2CARE | The Link2CARE intervention consists of 4 sessions. Session 1 consists of a one-on-one meeting with a Health Coach, during which participants will be offered an oral rapid HIV test and STI test. Sessions 2, 3, and 4 are group-based. During these sessions, participants will engage in discussions and activities regarding sexual and substance use risk behaviors. |
Timeline
- Start date
- 2017-12-09
- Primary completion
- 2021-09-30
- Completion
- 2022-12-01
- First posted
- 2017-12-11
- Last updated
- 2023-01-18
- Results posted
- 2022-11-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03369249. Inclusion in this directory is not an endorsement.